Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
PACS Group, Inc.
PACS
NYSE·Financial Services·Financial - Conglomerates·Mkt cap $7.0B
$44.48
▲ +0.36%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$7.50 - $45.20
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 239.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Diversified post-acute care portfolio across multiple communities
- Established operational expertise in senior living management since 2013
- Strategic positioning in high-demand healthcare services sector
- Integrated service model combining facilities, professionals, and ancillary support
Bear Case
1 risk
- Low volatility (beta 0.0).
Growth
Stable outlook
Aging U.S. population increasing demand for senior care services
Value
Fairly valued vs Healthcare Facilities peers
Momentum
Hot
+37.9% over 3m
Quality
Thin
Exceptional business - top-tier fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying PACS right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 7, 2026
MAY 11, 2026
Reported EPS of $0.50 vs $0.42 consensus (+19.1% surprise). Revenue of $1.4B vs $1.4B expected (+4.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+19.1%
Next: May 7, 2026
Revenue trend · last 8Q
—
—
+43%
+38%
+34%
+31%
+13%
+11%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$972.7M
$1.0B
$1.2B
$1.3B
$1.3B
$1.3B
$1.4B
$1.4B
Margins · last 8Q
Gross
—
Operating
—
Profit
5.7%
Wall Street consensus
4 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
$50.00
▲ +12.4% vs $44.48
Latest: Truist · $52.00 · May 18, 2026
2 analysts covering